Which one of the following preferentially activates plasminogen bound to fibrin and avoids the systemic lytic state –
**Core Concept**
Fibrinolysis is the physiological process of dissolving blood clots. Plasminogen is a precursor to the enzyme plasmin, which breaks down fibrin. The goal of fibrinolytic therapy is to activate plasminogen bound to fibrin, thereby avoiding the systemic lytic state that can occur with uncontrolled plasmin activation.
**Why the Correct Answer is Right**
The correct answer preferentially activates plasminogen bound to fibrin through a specific mechanism. This is achieved by the use of tissue plasminogen activator (tPA), which is a fibrin-specific activator. tPA works by binding to fibrin, where it then activates plasminogen to form plasmin. This targeted activation of plasminogen avoids the systemic activation of plasminogen, which can lead to a lytic state.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specifically activate plasminogen bound to fibrin. Instead, it activates plasminogen systemically, leading to a lytic state.
**Option B:** This option is incorrect because it is not a specific activator of plasminogen bound to fibrin. It may activate plasminogen systemically or have other off-target effects.
**Option C:** This option is incorrect because it is not a specific activator of plasminogen bound to fibrin. It may have other effects or be a non-specific activator.
**Clinical Pearl / High-Yield Fact**
When choosing a fibrinolytic agent, it's essential to select one that preferentially activates plasminogen bound to fibrin to avoid the systemic lytic state. This is particularly important in patients with bleeding risks or those who require ongoing anticoagulation.
**Correct Answer:** tPA (Tissue Plasminogen Activator).